Skip to main content

EFSA guidance outlines step-by-step approach for environmental risk assessment of GM animals

New guidance from the European Food Safety Authority (EFSA) provides applicants and risk assessors with a clear framework to evaluate the potential adverse effects of living genetically modified (GM) animals on the environment, including those on human and animal health. While no applications for GM animals have yet been received in the European Union (EU), scientific developments suggest future submissions may be made for a number of species A subdivision of the genus, a species is a group of closely related and similar-looking organisms; for example, in the case of Homo sapiens (humans), the second part of the name (sapiens) represents the species.. Therefore, the European Commission requested that EFSA develop environmental risk assessment A specialised field of applied science that involves reviewing scientific data and studies in order to evaluate risks associated with certain hazards. It involves four steps: hazard identification, hazard characterisation, exposure assessment and risk characterisation. ( ERA Environmental risk assessment (ERA) is the process of assessing potential harm to the environment caused by a substance, activity or natural occurrence. This may include the introduction of GM plants, the use of pesticides, or the spread of plant pests.) guidance for GM fish, insects, mammals and birds.

The vast majority of the GM animal ERA guidance has been newly developed by EFSA’s GMO A genetically modified organism (GMO) is an organism which contains genetic material that has been deliberately altered and which does not occur naturally through breeding or selection. Panel, and its publication is the culmination of several years’ work.  It was finalised following the consideration of more than 700 comments received from stakeholders and interested parties during a public consultation held last year. This work complements previous guidance by EFSA on the safety of food and feed from GM animals published in 2012 and completes the mandate from the Commission for comprehensive risk assessment guidelines on GM animals.

Data requirements and monitoring

Environmental risk assessments of GM animals must be carried out on a case-by-case basis which means the information required in applications may vary depending on aspects such as the animal type, the new trait being introduced and the intended use of the GM animal.

The guidance document lays down requirements for collecting, evaluating and generating key information to complete an ERA for a GM animal. These data would form an essential part of an application for a living GM animal to enter the EU market. The document also offers guidance for continuous post-market environmental monitoring ( PMEM Monitoring of the effects of a new product (e.g. a GM plant) following its release onto the market. This may reveal adverse effects which were not predicted in the risk assessment conducted prior to market release. It stands for post-market environmental monitoring.) and addresses animal health and welfare.

“The core of the guidance is that ERAs for GM animals must be carried out in a scientifically sound and transparent manner,” said Elisabeth Waigmann, head of EFSA’s GMO Unit. “They must be based on sufficient scientific and technical data that enable conclusions to be drawn on possible environmental risks posed by a living GM animal. The inclusion of a comprehensive uncertainty Scientific concept used in risk assessment to describe all types of limitations in available knowledge at the time an assessment is conducted, with the agreed resources, that affect the probability of possible outcomes to the assessment. analysis is of central importance given the current limitations in the availability, relevance and quality of data relating to GM animals.”

The guidance details three broad aspects that should form part of a rigorous ERA of GM animals. The first is the mandatory six-step evaluation procedure enshrined in EU legislation that forms the basis of the GMO Panel’s approach to environmental risk assessment. This approach should be followed by an assessment of seven areas of potential risk from GM fish, insects, mammals or birds that applicants are legally obliged to consider. (See Notes to editors for further explanation of these processes.)

Cross-cutting considerations

Thirdly, the GMO Panel has introduced a number of cross-cutting considerations that should be factored into the full GM animal ERA process. One of these is the use of so-called comparators – non-GM animals that serve as a baseline in the comparative risk assessment of GM animals. Another element is the use of appropriate surrogates, when this is considered necessary. A surrogate animal is one that does not bear the same genetic modification at issue but shares enough traits with the GM animal to act as its substitute in risk assessment tests and experiments. The guidance also describes methods for the identification and characterisation of environments into which GM animals might be released.

Crucially, EFSA specifies the methodology and reporting standards that should be observed in application data. The importance of clear guidance on experimental design, general statistical principles to be employed, the assessment of long-term effects and a detailed breakdown of several aspects of the uncertainty analysis A method of identifying the sources of uncertainty in a risk assessment calculation and estimating their size and direction so that errors can be taken into account. are all emphasised.

Notes to editors

In accordance with Directive 2001/18/EC, EFSA lists the six steps for the ERA of GM animals as: (1) problem formulation The process of defining the specific problem being addressed in, for example, an environmental risk assessment. It involves articulating a question and defining how it may be answered (e.g. by identifying the endpoints to be measured). including hazard A substance or activity which has the potential to cause adverse effects to living organisms or environments. and exposure Concentration or amount of a particular substance that is taken in by an individual, population or ecosystem in a specific frequency over a certain amount of time. identification; (2) hazard characterisation The second step in risk assessment, this involves defining the nature of the adverse health effects associated with biological, chemical and physical agents which may be present in food. The process should, if possible, involve an understanding of the doses involved and related responses.; (3) exposure characterisation; (4) risk characterisation The final stage of risk assessment, in which the likelihood that a particular substance will cause harm is calculated in the light of the nature of the hazard and the extent to which people, animals, plants and/or the environment are exposed to it.; (5) risk management The management of risks which have been identified by risk assessment. It includes the planning, implementation and evaluation of any resulting actions taken to protect consumers, animals and the environment. strategies; and (6) overall risk evaluation.

Under annex 2 of the same Directive, the seven areas of potential risk applicants must consider are: 1) persistence Persistence refers to the ability of harmful organisms like bacteria to survive and thrive despite regular cleaning and disinfection efforts, potentially lingering in hidden places for months or even years. and invasiveness of the GM animal, including vertical gene transfer; (2) horizontal gene transfer; (3) interactions of the GM animal with target organisms; (4) interactions of the GM animal with non-target organisms; (5) environmental impacts of the specific techniques used for the management of the GM animal; (6) impacts of the GM animal on biogeochemical processes; and (7) impacts of the GM animal on human and animal health.

How to contact us

EFSA Media Relations Office

Tel. +39 0521 036 149

E-mail: press [at] efsa.europa.eu (Press[at]efsa[dot]europa[dot]eu)

(Only if you are a member of the press)

Ask a Question Service

You have a question about EFSA’s work? Contact our Ask a Question service!

Ask a Question Service